BSE filing, NSE: ZENITHHE. Summary written from the filing by ALFA Finder's alert engine.
Zenith Healthcare Ltd: key numbers
- Share price
- ₹3.70
- Market cap
- ₹19.88 Cr
- Revenue (annual)
- ₹10.52 Cr
- Net profit (annual)
- ₹0.01 Cr
- P/E (TTM)
- 474.4×Sector 45.9×
- Promoter holding
- 28.74%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zenith Healthcare Ltd
All →Zenith Healthcare Q2 FY27 Results: Net Profit ₹0 Cr
Zenith Healthcare Ltd reported revenue from operations of ₹2 Cr (-13.0% YoY) and net profit of ₹0 Cr for Q2 FY27.
- Key figure
- Net profit ₹0 Cr
Zenith Healthcare Board Meeting Date
Zenith Healthcare has scheduled its Board meeting for 28 October 2026 to consider Q1 and H1 uneaudited financial results. No material decisions have been taken yet.
Zenith Healthcare Other Announcement
Zenith Healthcare Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Zenith Healthcare Management Change
Zenith Healthcare Limited has re-appointed Mr. Mahendra C. Raycha as Managing Director for a three-year term. The appointment was approved by the Board following committee recommendations.
- Execution
- 3 years
Zenith Healthcare Annual General Meeting
Zenith Healthcare Limited held its 32nd Annual General Meeting on August 28, 2026. Shareholders considered the adoption of FY26 financial statements and the re-appointment of directors.
Zenith Healthcare Q1 FY27 Results: Net Profit ₹0.1 Cr
Zenith Healthcare Ltd reported revenue from operations of ₹3.4 Cr (+6.2% YoY) and net profit of ₹0.1 Cr for Q1 FY27.
- Key figure
- Net profit ₹0.1 Cr
Other other announcement announcements
All →Maharaja & Speedex India Other Announcement
Maharaja & Speedex India filed its quarterly shareholding pattern as of 18 September 2026 under Regulation 31. It shows promoter and public holdings with no transaction or capital event.
Trio Mercantile & Trading Other Announcement
Trio Mercantile & Trading filed its quarterly shareholding pattern for the period ended 30 September 2026. The filing reports promoter and public holdings only, with no transaction or corporate event.
Pace Digitek Other Announcement
Pace Digitek submitted the Crisil Ratings monitoring agency report for the quarter ended September 30, 2026, on IPO proceeds. The report confirms utilisation is per the offer document, with no deviation from objects.
Valencia India Other Announcement
Valencia India reported no deviation in IPO fund use for six months ended September 2026. The Audit Committee-reviewed Regulation 32 statement was filed with BSE.
Neogen Chemicals Other Announcement
Neogen reports no deviation in QIP fund utilisation for the quarter ended September 30, 2026. This is a periodic utilisation report, not a new transaction.
GAMCO Other Announcement
Gamco Ltd filed its half-yearly related party transactions disclosure under Regulation 23(9) for the period ended 30 September 2026. The filing is a periodic cumulative statement with no new transaction or board decision.
- Execution
- Half year ended 30 September 2026